Calypso(R) Medical Technologies Inc. received FDA clearance for the Calypso 4D Localization System. The system utilizes proprietary electromagnetic technology in conjunction with implanted Beacon(R) transponders in the prostate. The product was designed to provide tumor location information during external beam radiation therapy without adding ionizing radiation.
During radiation therapy, the system can monitor organ motion for cancer patients. With clinicians expected to have greater knowledge of tumor location, it may ensure that the radiation beam is always on target. The product does not require expertise in interpreting X-ray or ultrasound images, so it reduces the time to perform patient setup.
June 07, 2022 
